Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2022 Filed Feb 16, 2022 02:15 UTC |
Cowdy Philip G.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006535 · doc4.xml · derivative · entry 2 Cowdy Philip G. · CIK 0001679773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested on February 11, 2022. F2 · derivative.expiration_date: The restricted stock units vested on February 11, 2022. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:15 UTC |
Cowdy Philip G.Director
|
Exercise / conversionClass A Common Stock | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006535 · doc4.xml · nonDerivative · entry 1 Cowdy Philip G. · CIK 0001679773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:17 UTC |
Nosenzo JohnChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,470 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006538 · doc4.xml · derivative · entry 3 Nosenzo John · CIK 0001835973 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,470 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vested on February 11, 2022. F4 · derivative.expiration_date: The restricted stock units vested on February 11, 2022. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:17 UTC |
Nosenzo JohnChief Commercial Officer
|
Exercise / conversionClass A Common Stock | 1,470 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006538 · doc4.xml · nonDerivative · entry 1 Nosenzo John · CIK 0001835973 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:14 UTC |
STALNECKER SUSAN MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006534 · doc4.xml · derivative · entry 2 STALNECKER SUSAN M · CIK 0001221375 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested on February 11, 2022. F2 · derivative.expiration_date: The restricted stock units vested on February 11, 2022. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:14 UTC |
STALNECKER SUSAN MDirector
|
Exercise / conversionClass A Common Stock | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006534 · doc4.xml · nonDerivative · entry 1 STALNECKER SUSAN M · CIK 0001221375 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 20:31 UTC |
HAWKINS WILLIAM ADirector
|
Exercise / conversionPhantom Profit Units · Derivative | 38,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006324 · doc4.xml · derivative · entry 2 HAWKINS WILLIAM A · CIK 0001106508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 38,288 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 20:31 UTC |
HAWKINS WILLIAM ADirector
|
Exercise / conversionClass A Common Stock | 38,288 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006324 · doc4.xml · nonDerivative · entry 1 HAWKINS WILLIAM A · CIK 0001106508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:43 UTC |
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER
|
Exercise / conversionPhantom Profit Units · Derivative | 191,708 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006333 · doc4.xml · derivative · entry 3 Pavesio Alessandra · CIK 0001835185 · SVP & CHIEF SCIENCE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 191,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:43 UTC |
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER
|
Tax withholdingClass A Common Stock | 73,915 | $12.88 | $952,025.20 |
DisclosureSEC source: 0000899243-22-006333 · doc4.xml · nonDerivative · entry 2 Pavesio Alessandra · CIK 0001835185 · SVP & CHIEF SCIENCE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,793 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:43 UTC |
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER
|
Exercise / conversionClass A Common Stock | 191,708 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006333 · doc4.xml · nonDerivative · entry 1 Pavesio Alessandra · CIK 0001835185 · SVP & CHIEF SCIENCE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC |
Nosenzo JohnCHIEF COMMERCIAL OFFICER
|
Exercise / conversionPhantom Profit Units · Derivative | 66,139 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006332 · doc4.xml · derivative · entry 3 Nosenzo John · CIK 0001835973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 66,139 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC |
Nosenzo JohnCHIEF COMMERCIAL OFFICER
|
Tax withholdingClass A Common Stock | 24,205 | $12.88 | $311,760.40 |
DisclosureSEC source: 0000899243-22-006332 · doc4.xml · nonDerivative · entry 2 Nosenzo John · CIK 0001835973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,434 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC |
Nosenzo JohnCHIEF COMMERCIAL OFFICER
|
Exercise / conversionClass A Common Stock | 66,139 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006332 · doc4.xml · nonDerivative · entry 1 Nosenzo John · CIK 0001835973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:35 UTC |
Anglum Gregory O.SVP & CFO
|
Exercise / conversionPhantom Profit Units · Derivative | 65,581 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006327 · doc4.xml · derivative · entry 3 Anglum Gregory O. · CIK 0001680271 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 65,581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:35 UTC |
Anglum Gregory O.SVP & CFO
|
Tax withholdingClass A Common Stock | 19,674 | $12.88 | $253,401.12 |
DisclosureSEC source: 0000899243-22-006327 · doc4.xml · nonDerivative · entry 2 Anglum Gregory O. · CIK 0001680271 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,907 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:35 UTC |
Anglum Gregory O.SVP & CFO
|
Exercise / conversionClass A Common Stock | 65,581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006327 · doc4.xml · nonDerivative · entry 1 Anglum Gregory O. · CIK 0001680271 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:37 UTC |
D'Adamio AnthonySVP & General Counsel
|
Exercise / conversionPhantom Profit Units · Derivative | 21,165 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006329 · doc4.xml · derivative · entry 3 D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 21,165 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:37 UTC |
D'Adamio AnthonySVP & General Counsel
|
Tax withholdingClass A Common Stock | 6,599 | $12.88 | $84,995.12 |
DisclosureSEC source: 0000899243-22-006329 · doc4.xml · nonDerivative · entry 2 D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,566 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:37 UTC |
D'Adamio AnthonySVP & General Counsel
|
Exercise / conversionClass A Common Stock | 21,165 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-006329 · doc4.xml · nonDerivative · entry 1 D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:10 UTC |
McMurry-Heath MichelleDirector
|
GrantRestricted Stock Units · Derivative | 1,157 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001750 · doc4.xml · derivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157 Underlying: Class A Common Stock · 1,157 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantRestricted Stock Units · Derivative | 2,895 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 8 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,895 Underlying: Class A Common Stock · 2,895 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock F5 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 261,794 | Not disclosed Strike: $12.71 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 7 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,794 Underlying: Class A Common Stock · 261,794 shares Expires 2030-06-29 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 89,001 | Not disclosed Strike: $7.78 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 6 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,001 Underlying: Class A Common Stock · 89,001 shares Expires 2030-06-29 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 347,323 | Not disclosed Strike: $5.63 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 5 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,323 Underlying: Class A Common Stock · 347,323 shares Expires 2030-05-13 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 34,905 | Not disclosed Strike: $12.27 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 4 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,905 Underlying: Class A Common Stock · 34,905 shares Expires 2029-11-22 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 19,634 | Not disclosed Strike: $4.13 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 3 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,634 Underlying: Class A Common Stock · 19,634 shares Expires 2026-02-04 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 6,544 | Not disclosed Strike: $3.33 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 2 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,544 Underlying: Class A Common Stock · 6,544 shares Expires 2023-12-03 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:17 UTC |
Vizirgianakis Stavros G.Director
|
GrantStock Option (Right to Buy) · Derivative | 26,179 | Not disclosed Strike: $7.57 | Not disclosed |
DisclosureSEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 1 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,179 Underlying: Class A Common Stock · 26,179 shares Expires 2025-02-03 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:20 UTC |
Beyer PatDirector
|
GrantRestricted Stock Units · Derivative | 2,895 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042370 · doc4.xml · derivative · entry 2 Beyer Pat · CIK 0001627985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,895 Underlying: Class A Common Stock · 2,895 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (I) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in teach case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (I) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in teach case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:20 UTC |
Beyer PatDirector
|
GrantStock Option (Right to Buy) · Derivative | 34,906 | Not disclosed Strike: $10.94 | Not disclosed |
DisclosureSEC source: 0000899243-21-042370 · doc4.xml · derivative · entry 1 Beyer Pat · CIK 0001627985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,906 Underlying: Class A Common Stock · 34,906 shares Expires 2031-05-14 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); by (B) the Option Exchange Ratio (as defined in the Merger Agreement), F3 · price: (Continued from Footnote 2) rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 29, 2021 Filed Apr 28, 2022 20:24 UTC |
Vizirgianakis Stavros G.Director
|
GrantClass A Common Stock | 2,780,923 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-015851 · doc4.xml · nonDerivative · entry 1 Vizirgianakis Stavros G. · CIK 0001559834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,780,923 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each share of Misonix Inc. ("Misonix") common stock (a "Misonix Option") that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into the right to receive a per share amount (the "Merger Consideration") equal to either an amount in cash equal to $28.00 or 1.6839 validly issued, fully paid and non-assessable shares of the Company's Class A Common Stock, $0.001 par value per share ("Bioventus Shares"). The transaction was exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3 promulgated thereunder. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 13:22 UTC |
Reali Kenneth MichaelDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseClass A Common Stock | 1,800 | $14.81 | $26,658.00 |
DisclosureSEC source: 0000899243-21-035518 · doc4.xml · nonDerivative · entry 1 Reali Kenneth Michael · CIK 0001480801 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,175 Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 22:41 UTC |
Ladone Mary KayDirector
|
GrantRestricted Stock Units · Derivative | 5,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-028863 · doc4.xml · derivative · entry 1 Ladone Mary Kay · CIK 0001760737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,440 Underlying: Class A Common Stock · 5,440 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:34 UTC |
SUTTER MARTIN PDirector
|
GrantRestricted Stock Units · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014839 · doc4.xml · derivative · entry 1 SUTTER MARTIN P · CIK 0001017832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Class A Common Stock · 2,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:35 UTC |
HAWKINS WILLIAM ADirector
|
GrantRestricted Stock Units · Derivative | 40,573 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014840 · doc4.xml · derivative · entry 1 HAWKINS WILLIAM A · CIK 0001106508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,573 Underlying: Class A Common Stock · 40,573 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:40 UTC |
STALNECKER SUSAN MDirector
|
GrantRestricted Stock Units · Derivative | 23,416 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014848 · doc4.xml · derivative · entry 1 STALNECKER SUSAN M · CIK 0001221375 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,416 Underlying: Class A Common Stock · 23,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:38 UTC |
Pavesio AlessandraSVP & Chief Science Officer
|
GrantStock Options · Derivative | 4,900 | $0.00 Strike: $15.23 | $0.00 |
DisclosureSEC source: 0000899243-21-014846 · doc4.xml · derivative · entry 3 Pavesio Alessandra · CIK 0001835185 · SVP & Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 Underlying: Class A Common Stock · 4,900 shares Expires 2031-03-31 F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:38 UTC |
Pavesio AlessandraSVP & Chief Science Officer
|
GrantRestricted Stock Units · Derivative | 61,476 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014846 · doc4.xml · derivative · entry 2 Pavesio Alessandra · CIK 0001835185 · SVP & Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,476 Underlying: Class A Common Stock · 61,476 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:35 UTC |
Anglum Gregory O.SVP & General Counsel
|
GrantStock Options · Derivative | 9,100 | $0.00 Strike: $15.23 | $0.00 |
DisclosureSEC source: 0000899243-21-014841 · doc4.xml · derivative · entry 3 Anglum Gregory O. · CIK 0001680271 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 Underlying: Class A Common Stock · 9,100 shares Expires 2031-03-31 F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:35 UTC |
Anglum Gregory O.SVP & General Counsel
|
GrantRestricted Stock Units · Derivative | 96,876 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014841 · doc4.xml · derivative · entry 2 Anglum Gregory O. · CIK 0001680271 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,876 Underlying: Class A Common Stock · 96,876 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:37 UTC |
D'Adamio AnthonySVP & General Counsel
|
GrantStock Options · Derivative | 9,500 | $0.00 Strike: $15.23 | $0.00 |
DisclosureSEC source: 0000899243-21-014843 · doc4.xml · derivative · entry 3 D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Class A Common Stock · 9,500 shares Expires 2031-03-31 F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:37 UTC |
D'Adamio AnthonySVP & General Counsel
|
GrantRestricted Stock Units · Derivative | 37,476 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014843 · doc4.xml · derivative · entry 2 D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,476 Underlying: Class A Common Stock · 37,476 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:33 UTC |
Parker David JDirector
|
GrantRestricted Stock Units · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014835 · doc4.xml · derivative · entry 1 Parker David J · CIK 0001299047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Class A Common Stock · 2,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:32 UTC |
NOHRA GUY PDirector
|
GrantRestricted Stock Units · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014834 · doc4.xml · derivative · entry 1 NOHRA GUY P · CIK 0001198330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Class A Common Stock · 2,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:31 UTC |
Cowdy Philip G.Director
|
GrantRestricted Stock Units · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014833 · doc4.xml · derivative · entry 1 Cowdy Philip G. · CIK 0001679773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Class A Common Stock · 2,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:31 UTC |
Reali Kenneth MichaelDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 30,000 | $0.00 Strike: $15.23 | $0.00 |
DisclosureSEC source: 0000899243-21-014831 · doc4.xml · derivative · entry 2 Reali Kenneth Michael · CIK 0001480801 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:31 UTC |
NEELS GUIDO JDirector
|
GrantRestricted Stock Units · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014830 · doc4.xml · derivative · entry 1 NEELS GUIDO J · CIK 0001222362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Class A Common Stock · 2,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:31 UTC |
Nosenzo JohnChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 106,485 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014832 · doc4.xml · derivative · entry 2 Nosenzo John · CIK 0001835973 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,485 Underlying: Class A Common Stock · 106,485 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date. Read SEC document |
| April 01, 2021 Filed Apr 14, 2026 22:19 UTC Amendment |
Cowdy Philip G.Director
|
GrantRestricted Stock Units · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001679773-26-000004 · wk-form4a_1776205186.xml · derivative · entry 1 Cowdy Philip G. · CIK 0001679773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,700 shares Expires not disclosed F1 · security: On April 5, 2021, the Issuer inadvertently filed a Form 4 reporting a grant of restricted stock units that were not accepted by the Reporting Person. As of April 1, 2021, the Reporting Person held no non-derivative or derivative securities of the Issuer. F2 · derivative.exercise_price: None. F2 · derivative.exercise_date: None. F2 · derivative.expiration_date: None. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.